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Abstract
Background: Crohn’s disease (CD) and ulcerative colitis (UC), the two main types of inflammatory bowel disease
(IBD), are multifactorial conditions of unknown etiology. The objective of this study is to examine the combined
gene-environment interactions influencing IBD susceptibility in a well-defined Caucasian cohort in rural mid-
America.
Methods: Patients were diagnosed to have CD or UC using conventional radiologic, endoscopic, and/or
histopathologic findings. Histological diagnosis was made by a single specialist gastrointestinal pathologist with a
particular interest in IBD. Information regarding cigarette smoke exposure was obtained by administration of the
Behavioral Risk Factor Surveillance System Survey (BRFSS) to all patients. Genomic DNA was extracted from
peripheral blood leukocytes, and polymerase chain reaction (PCR) amplification and genotyping were performed
for 11 Single Nucleotide Polymorphisms (SNP) in NOD2, IL23r, OCTN1 genes along with IGR.
Results: Our cohort consists of 1196 patients: 435 controls, 485 CD patients, and 276 UC patients. Only patients
with genotype data for at least 7 of 11 SNPs were included in our data analysis. The control groups for all 11 SNPs
were in Hardy-Weinberg Equilibrium. In genotype-association SNP analysis, all NOD2 SNPs (rs5743293, rs2066844,
rs2066845) and the IL23r SNP (rs11465804) showed a significant association to IBD (p < 0.03). A multiple gene-
interaction analysis showed an association between NOD2 and IL23r with UC (p = 0.04). There were no associations
between any OCTN1 and IGR SNPs and IBD in this cohort. A multivariable logistic regression analysis showed that
female gender, “current” or “former” smoking status, family history of IBD, and NOD2 SNP minor alleles were
associated with CD.
Conclusion: IBD remains to be challenging to properly diagnose, characterize, and treat. Our study proposes a
combined genetic, phenotypic, and environmental approach in an attempt to better understand IBD. Previously
demonstrated associations between OCTN1 and IGR and IBD were not confirmed.
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Background
Inflammatory bowel disease (IBD) is a chronic inflam-
matory disorder of the gastrointestinal (GI) tract, com-
prised of Crohn’s disease (CD) and ulcerative colitis
(UC). Over the past century, Northern Europe and
North America have witnessed a significant rise in inci-
dences of IBD [1]. The inflammatory response in CD
patients is described by transmural inflammation in any
portion of the gastrointestinal tract while that of UC is
usually limited to the mucosa and submucosa of the
colon and rectum [2]. Although the exact pathogenesis
is not completely known in IBD, our current under-
standing suggests a disease etiology dependent upon a
multifaceted interaction between genetic, environmental,
and clinical factors[3].
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any medium, provided the original work is properly cited.Evidence of genetic factors implicated in this condition
is supported by increased rates of IBD in monozygotic
twins, and the ethnic differences in IBD frequency [4]. In
addition, different races and ethnic groups have different
degrees of susceptibility to IBD [5]. A number of studies
have shown an association between IBD susceptibility and
the nucleotide-binding oligomerization domain 2 gene
(NOD2, also known as CARD15), interleukin-23 receptor
gene (IL23r), organic cation transporter novel type 1 gene
(OCTN1), and the intergenic region (IGR) variants [6-9].
NOD2 gene mutations have been extensively studied and
described in the literature in terms of IBD susceptibility.
Loss-of-function mutations in NOD2 gene appear to be
the most significant for development of IBD, although the
mechanism that increases disease susceptibly is poorly
understood. One report suggests that NOD2 contributes a
protective function in host defense that when compro-
mised elicits a loss in immune bacterial recognition [10].
The NOD2 gene on chromosome 16 has been specifically
implicated in susceptibility to CD with 30-50% of Cauca-
sian CD patients having variants of this gene [6]. The
three NOD2 variant single nucleotide polymorphisms
(SNPs) (rs2066844, rs2066845, and rs5743293) have been
strongly associated with clinical presentation of inflamma-
tory bowel disease [1,11].
Environmental factors are likely to contribute to IBD
susceptibility; however, they are poorly understood and
insufficiently described. The recent alarming rise in IBD
incidence in the US points to changes in environmental
factors rather than drastic alterations in allele frequency,
since genetic remodeling could not occur over such a
brief time [12]. It seems plausible that environmental
influences play as significant a role as their genetic
counterparts and their combined actions dramatically
affect disease presentation [13].
The objective of this study is to examine the gene-
environment interaction which may influence the causa-
tion of IBD. We aimed to:
1. Study the incidence of SNP variants in NOD2,
IL23r, OCTN1,a n dt h eIGR genes in a unique well-
characterized rural Caucasian IBD population.
2. Examine haplotype frequencies in NOD2, IL23r, and
IGR genes in both CD and UC patients.
3. Explore the SNPs’ interaction, their possible effect
on IBD susceptibility, and report a possible signature
interaction model that could differentiate CD and UC
patients.
4. Report risk factors that could serve as clinical pre-
dictors of IBD susceptibility
Results
Population Description
For the purposes of our genetic and clinical compari-
sons, we only examined the Caucasian subset in order
to maintain statistical and descriptive homogeneity. Our
patient population was composed of 1196 unrelated
patients (63% women): 435 controls, 485 CD patients,
and 276 UC patients.
The mean age at time of IBD diagnosis was 31 years.
Twenty-seven percent of patients reported a family his-
tory of IBD. The smoking status of the population was
defined as follows; 21% as “current” smokers, 30% as
“former” smokers and 49% as “never” smokers. Our CD
patients were described using the Vienna classification
system (Table 1). Sixty-five percent of UC patients had
pan-colitis, 22% had left-sided colitis and 13% isolated
proctosigmoiditis.
Analysis of Clinical Variables
Univariate analysis of UC vs.C De x a m i n e dp r e v i o u s l y
described relevant clinical factors associated with IBD.
Gender, smoking status, number of IBD-associated
operations, and family history of IBD were strong indi-
cators of CD (p< 0.002). Age at diagnosis above 27
years old was more predictive of UC (p=0.003).
SNP and Haplotype Analysis
For SNP analysis, we included only data for patients
successfully genotyped for at least 7 out of 11 SNPs.
Thus, there were 909 patients remaining for analysis, as
follows: 303 controls, 366 CD patients, and 223 UC
patients. The control groups for all 11 SNPs were in
HWE. Univariate analysis was performed on all 11
SNPs. In genotype-association SNP analysis, only the
NOD2 SNPs (rs5743293, rs2066844, rs2066845) and
IL23r SNP-rs11465804 showed a significant association
with IBD (p< 0.025) (Table 2). The minor alleles in
NOD2 SNPs (rs5743293 and rs2066845) in addition to
IL23r SNP-rs11465804, were associated with CD (p ≤
Table 1 Characteristics of CD patients using Vienna
Classification
Characteristic CD Patients*
Vienna Age N (%)
A1 (< 40 yrs) 372 (77)
A2 (> 40 yrs) 111 (23)
Vienna Behavior N (%)
B1 (Non-stricturing, non-penetrating) 110 (23)
B2 (Stricturing) 131 (27)
B3 (Penetrating) 240 (50)
Vienna Location N (%)
L1 (Terminal ileum) 129 (27)
L2 (Colon) 146 (31)
L3 (Ileocolon) 169 (35)
L4 (Upper GI) 32 (7)
*Based on available clinical data
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allele was associated with both CD and UC (p< 0.005),
but was more significantly associated with CD. We also
examined the genetic interaction between NOD2 and
IL23r genes for UC and CD; this interaction was predic-
tive for UC (p=0.04), but not for CD (p=0.63).
The overall haplotype test was significant (p< 0.0001) for
NOD2, with significant differences in the frequencies of
rare haplotypes, with both C-C-G (p=0.008) and C-C-C
(p=0.018) being more associated with CD than with UC
(Table 3). With IL23r gene, the C-A-C-G-G haplotype was
associated with CD (p=0.009), while the T-A-C-G-G
haplotype was associated with UC (p=0.023) (Table 4).
IGR gene analysis showed there was no overall haplotype
a s s o c i a t i o nw i t hC Do rU C( p=0.98 and 0.063).
Multivariate Analysis of Genetic and Clinical Predictors
(CD vs. UC)
We used a multivariable logistic regression model compris-
ing the most significant clinical predictors and the above
mentioned SNP variants implicated in IBD (Table 5). The
IL23r SNP-rs11465804 was not included in the regression
analysis since its correlative affect in IBD was not as signifi-
cant as its NOD2 counterparts. Female gender, current or
former smoking status, IBD-associated surgery, family his-
tory of IBD, and frequency of all NOD2 SNP minor alleles
were descriptive predictors of CD. Age at time of diagnosis
≥ 27 years was predictive of UC diagnosis.
Discussion
I. Current Diagnosis of IBD
IBD is a complex genetic disorder based on a multifa-
ceted interaction between specific genes and environ-
mental factors. The definitive diagnosis and correct
identification of IBD remains difficult. IBD diagnostic
markers may be lacking in the earliest stages of disease
[14]. Radiologic, endoscopic, and histological diagnostic
approaches are commonly employed in identification of
IBD; however, the inter-observer variability between
pathologists calls into question their true clinical value.
Distinction between CD and UC, particularly in the case
of colonic IBD is important since surgical management
varies in each disease, however, in many instances the
pathological features overlap making differentiation pro-
blematic [15]. Particularly in CD where variability of his-
tological presentation makes accurate diagnosis a
challenging exercise, pathologists often differ on their
individual assessments [16]. The apparent complexity of
successful IBD diagnosis with current techniques
demonstrates the immense value of developing a genetic
and clinical screening tool.
II. Clinical and Environmental Predictors of IBD
There are several established clinical descriptors asso-
ciated with IBD. Our analysis identified age at diagnosis,
gender, smoking status, and family history of IBD as
being the most important clinical predictors to
Table 2 Univariate Analysis of Allelic Association in SNPs
Single Nucleotide Polymorphism Total # of Alleles
(Total = 1644)
(N, %)
Control
(Total = 582)
(N, %)
Crohn’s Disease
(Total = 654)
(N, %)
Ulcerative Colitis
(Total = 408)
(N, %)
p-value
NOD2 - rs5743293 < 0.001
1
C 59 (4) 8 (1) 43 (7) 8 (2) < 0.0001
2
N 1499 (96) 546 (99) 561 (93) 392 (98) 0.509
3
< 0.001
4
NOD2 - rs2066844 < 0.001
1
C 1377 (93) 466 (97) 545 (89) 366 (93) < 0.001
2
T 109 (7) 14 (3) 67 (11) 28 (7) 0.004
3
0.042
4
NOD2 - rs2066845 < 0.001
1
G 1558 (98) 560 (99) 601 (96) 397 (99) < 0.001
2
C 38 (2) 6 (1) 27 (4) 5 (1) 1.000
3
0.006
4
IL-23r - rs11465804 0.022
1
G 67 (4) 30 (5) 16 (3) 21 (5) 0.010
2
T 1545 (96) 534 (95) 630 (97) 381 (95) 0.948
3
0.019
4
1 Global (Fisher’s Exact Test)
2 Control versus CD
3 Control versus UC
4 CD versus UC
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these factors are significantly related to IBD, but failed
to adequately describe their effects.
A. Age at Time of Diagnosis
Loftus et al. described a systematic review of North
Americans with CD and UC in respect to patient age at
time of diagnosis. The mean age for CD diagnosis ran-
ged from 33 - 45 years [17] while UC patients were
diagnosed 5 - 10 years [18,19] later. In concordance
with these reports, the median age at time of diagnosis
in our cohort was found to be 27 years. The age at time
of diagnosis of ≥ 27 years age was found to be more
predictive of UC patients (p = 0.04).
B. Gender
In a separate report, Loftus and Sandborn described the
influence of gender on disease occurrence for CD and
UC [20]. They reported an increased incidence of UC
among men, and CD among women [20]. Our analysis
c o n c u r sw i t ht h i s ;t h eC a u c a s i a n si nt h i ss t u d ys h o w e d
increased diagnosis of CD in women and UC in men (p=
0.014). The female predominance in CD could possibly
be attributed to unspecified hormonal interactions [1].
C. Family History of IBD
The positive correlation between family history and IBD
incidence seems plausible; this is possibly due to a com-
bination of underlying genetic and environmental
factors. This was shown in a study done at a University
Hospital in Finland where a comparison among IBD
patients revealed 16% of CD patients and 14% of UC
patients had at least one family member afflicted with
I B D[ 2 1 , 2 2 ] .O u rd a t as t r o n g l ys u p p o r tt h e s ec o n c l u -
sions; i.e. a family history of IBD being more predictive
of predisposition to CD than to UC (p < 0.0001).
D. Number of Surgeries
In addition to independent factors of gender, age, and
family history, treatment approach may also be descrip-
tive in IBD severity and progression. A North American
population based study reported that 43% of patients
with CD required major surgery involving incision, exci-
sion, and intestinal anastomosis compared to 40% for all
UC hospitalizations [21]. Our results showed similar
findings; CD patients were more likely to require sur-
gery than their UC counterparts (p=0.015).
E. Smoking Status
Smoking was originally recognized as a risk factor for
IBD susceptibility over 25 years ago [23,24]. A meta-
analysis performed by Mahid et al. showed that 12 of 13
reports found that “current” smoking status could be
protective against UC development. In contrast, “for-
mer” smoker status was found to be associated with an
increased risk for the development of UC. A parallel
analysis of Crohn’s patients revealed 6 of 9 reports
Table 3 NOD2 Haplotype Association Analysis
SNPs Haplotype Frequencies
Haplotype Control CD UC CD and UC combined p-value (CD vs. UC)
rs574329 - rs2066844 C-C 1.34 6.46 1.97 4.75 < 0.0001
rs574329 - rs2066845 C-G 1.47 5.3 1.97 4.02 0.004
NOD-2 gene C-C 0 1.18 0 0.74 0.027
rs2066844- rs2066845 C-C 1.13 3.54 1.09 2.64 0.009
rs574329 - rs2066844- rs2066845 C-C-G 1.35 5.27 1.97 4.01 0.008
C-C-C 0 1.19 0 0.75 0.018
Table 4 IL23r Haplotype Association Analysis
Frequencies (%)
SNPs Haplotype Control CD UC CD and UC combined p-value
(CD vs. UC)
rs10489629 - rs11465804 G-G 3.91 2.25 4.52 3.16 0.048
rs1004819 - rs10489629 -rs11465804 C-G-G 3.94 2.06 4.36 2.95 0.045
rs1004819 - rs2201841 - rs11465804 - rs11209026 T-C-G-G 0.01 0.02 1.1 0.45 0.014
C-C-G-G 0 0.353 0 0.002 0.010
rs1004819 - rs10489629 -rs11465804 - rs11209026 C-A-G-G 0.4 0.78 0 0.1 0.016
T-A-G-G 0.03 0.006 1.34 0.61 0.028
rs1004819 - rs10489629 - rs2201841 - rs11465804 C-G-T-G 3.92 2.14 4.37 3.02 0.049
C-A-C-T 4.97 4.07 7.19 5.1 0.048
rs1004819 - rs10489629 - rs2201841 - rs11465804 - rs11209026 T-A-C-G-G 0.01 0.02 1.12 0.41 0.023
C-A-C-G-G 0 0.36 0 0.008 0.009
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ing “ever smoked” [3]. Analysis of our patient cohort,
“current” and “former” smoker statuses were both more
associated with development of CD than UC (p < 0.001).
III. Genetic Predictors of IBD
NOD2 gene is identified to be in the IBD1 locus on
chromosome 16 as a CD susceptibility gene. Hugot et
al.m a p p e dt h eIBD1 linkage locus and identified NOD2
as the underlying IBD susceptibility gene in 2001[25].
Thirty non-conservative polymorphisms have been iden-
tified within this gene, but three single SNPs
(rs2066844, rs2066845, and rs5743293) account for
approximately 82% of the mutated alleles [26]. Replica-
tion studies have confirmed that these three SNPs are
independently associated with disease [11,27,28].
The receptor for the proinflammatory cytokine, IL-
23r, also appears to play a key role in the progression of
the chronic inflammation found in CD by driving
inflammation through its role in the T-helper 17 (Th17)
response. Activated myeloid and T cells express the IL-
23 receptor and the level of its expression may affect
the way Th17 cells create excess mucosal inflammation
[9].
A. NOD2 and IL23r SNPs
In our patient population, all NOD2 variants and one
IL23r variant were associated with IBD. After multivari-
able logistic regression analysis, only the NOD2 SNPs
(rs2066844, rs2066845, and rs5743293) remained highly
significant predictors of disease (p< 0.001), and in this
context all were descriptive of CD, in agreement with
previous reports. A meta-analysis conducted by Econo-
mou et al.f o u n dt h es a m et h r e eNOD2 variants to be
distinguishing risk factors for CD. According to their
analyses, SNP rs5743293 carries a four-fold increase,
rs2066845 a three-fold increase, and rs2066844 a two-
fold increase of developing CD in non-Jewish descent
Caucasians. They further reported that the combination
of two of these NOD2 variants resulted in an increased
odds of developing CD of 17 times the normal popula-
tion [29]. In contrast to NOD2 SNPs, we did not find
the same genetic importance associated with IL23r poly-
morphisms in terms of describing and characterizing
IBD. Although only one IL23r SNP was marginally sig-
nificant in our univariate analysis, another variation of
this allele yielded notable results when present with a
NOD2 variant. A combination of NOD2 rs2066844 and
IL23r rs2201841 was descriptive of patients with UC
compared to controls (p=0.04). No such association
was found for CD patients.
B. Haplotype Analysis for NOD2 and IL23r
Another potential differentiator between CD and UC is
haplotype analysis. Previous reports implicated numer-
ous NOD2 and IL23r haplotype sequences associated to
CD [30,31]. The exact mechanism for disease pathogen-
esis in terms of these NOD2 and IL23r SNPs remains
unclear, but an understanding of how allelic combina-
t i o n sa l t e rt h ec o u r s eo fd i s e a s em a yp r o v eu s e f u l .I n
Table 5 Multivariable Logistic Regression Analysis for UC vs.C D
Genetic and Clinical Variables Ulcerative Colitis vs. Crohn’s Disease
Estimate* p-value OR (95% CI)
Age at time of diagnosis ≥ 27 0.32 0.04 1.38 (1.02-1.87)
<2 7 0
Gender Female -0.38 0.01 0.68 (0.50-0.92)
Male 0
Smoker Status Current -1.63 < 0.0001 0.20 (0.13-0.30)
Former -0.81 < 0.0001 0.45 (0.32-0.63)
Never 0 < 0.0001
Number of Operations Yes -0.63 0.002 0.53 (0.36-0.79)
No 0
Family History IBD Yes -0.88 < 0.0001 0.42 (0.30-0.57)
No 0
NOD2 - rs5743293 C -1.72 0.0002 0.18 (0.07-0.44)
N0
NOD2 - rs2066844 T -0.60 0.03 0.55 (0.33-0.93)
C0
NOD2 - rs2066845 C -1.30 0.02 0.271 (0.09-0.84)
G0
* A positive estimate indicates the variable being more predictive of ulcerative colitis while a negative estimate is more predictive of Crohn’s disease.
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associated with CD: C-C-C and C-C-G (rs5743293-
rs2066844-rs2066845). With respect to the IL23r gene,
one haplotype was associated with CD and one with
UC: Haplotypes C-A-C-G-G with CD and T-A-C-G-G
with UC (rs1004819-rs10489629-rs2201841-rs11465804-
rs11209026). Although potentially useful as genetic
descriptors of CD and UC, the rarity of these haplotypes
makes their clinical use unlikely.
Conclusion
Inflammatory bowel disease remains difficult to properly
characterize, diagnose, and treat. Understanding the
combined interactions between clinical, environmental,
and genetic factors could serve as key in identifying IBD
predictors as well as in properly differentiating between
UC and CD. Our report implicates “female gender”,
“current” or “former” smoking status, positive family
history of IBD, and NOD2 SNP minor alleles to be asso-
ciated with CD. Clinically, this will help physicians iden-
tify patients with high risk for IBD development,
differentiate CD from UC patients, and eventually help
better tailor their medical/surgical treatment approach.
Methods
Population Selection and Classification
This study was approved by the University of Louisville
Institutional Review Board (IRB). Written informed con-
sent was obtained from all subjects. Genetic and clinical
information was stored in a password-protected, pro-
spectively maintained HIPAA compliant database.
Patients were derived from a clinically well-described
university-based IBD practice [4] and from a small rela-
tively rural geographic area consisting of the state of
Kentucky and southern Indiana. Our cohort is com-
posed of 1337 patients (37% males and 63% females). It
is comprised of unrelated individuals of various races
(90% Caucasian, 7% African American, and 3% Asians).
For the purpose of this study, we decided to study IBD
in a uniform well-described group of patients, specifi-
cally Caucasians (n = 1196). These patients were not
studied for IBD before. There is a profound environ-
mental effect in our studied population as they are
derived from one of the areas in the United States with
the highest rates of adult cigarette smoking. Addition-
ally, thirty seven percent of all IBD patients in our
cohort have a positive family history of IBD, defined as
a first or second degree relative with IBD, as compared
to only 9% of controls. Perianal CD (PCD) occurred in
147 (46%) of CD patients. All patients were diagnosed
to have IBD, using conventional radiologic, endoscopic,
and/or histopathologic findings. In cases of IBD colitis,
the diagnosis was confirmed by a single specialist gas-
trointestinal pathologist with a particular interest in
IBD. CD patients and their clinical characteristics, in
terms of age at diagnosis, disease location, and behavior
were classified according to Vienna classification [32].
Disease location in UC was classified as rectosigmoid,
left-sided, or Pancolitis. Comparator patients to function
as controls included patients from the same geographic
area seen for non-inflammatory, non-neoplastic disor-
ders including hemorrhoidal disease and screening
colonoscopy.
Characterization of Environmental Risk
This included smoking status and it was verified by uti-
lizing a validated Behavioral Risk Factor Surveillance
Survey (BRFSS) that was prospectively administered.
[24] “Current smoking” was defined as having smoked
100 cigarettes in one’s lifetime and smoking every day
or some days over the past six months.
24 “Former smok-
ing” was defined as having smoked 100 cigarettes in
one’s lifetime but currently no longer smoking at all.
[24] A “non-smoker” is defined as someone who has not
smoked 100 cigarettes in his or her lifetime and who
does not currently smoke.
24 The category “ever smoking”
includes individuals from both the current and former
smoking groups, while those who “never smoked“
includes only non-smokers. [24]
Characterization of Clinical Data
Clinical data included gender, family history of IBD and
cancer, age at time of diagnosis, presence of extra intest-
inal or perianal disease, number of IBD-associated sur-
geries (as a surrogate index for disease severity), and
recurrence in CD.
Characterization of NOD2, IL23R, OCTN, and IGR
Polymorphisms
Peripheral blood was obtained and genomic DNA was
then extracted with a Puregene
® DNA extraction kit
(Gentra Systems Inc., Minneapolis, MN). Polymerase
chain reaction (PCR) amplification and genotyping were
performed on an ABI prism 7300 sequence detection
system (Applied Biosystems
©, Foster City, CA). Taq-
Man
® SNP-specific PCR primers and fluorogenic probes
were obtained from by Applied Biosystems (Applied
Biosystems
©, Foster City, CA). The fluorogenic minor
groove binder (MGB) TaqMan
® probes were labeled
with a reporter dye, either FAM ([5-(&6)-carboxyfluor-
escein]) or VICs (a proprietary fluorescent dye produced
by Applied Biosystems) specific for the wildtype and
variant alleles of each of the following SNPs[33,34]
(additional file 1):
1- Three NOD2 SNPs: rs5743293, rs2066844,
rs2066845.
2- Five IL23r SNPs: rs1004819, rs10489629,
rs2201841, rs11465804, and rs11209026.
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4- One OCTN SNP: rs1050152.
Statistical Methods
Descriptive statistics related to genetic and clinical char-
acteristics were produced for the entire cohort. Catego-
rical variables were compared using the Pearson Chi-
square test (or Fisher’s Exact test) for contingency tables
[34]. The t-test or Wilcoxon rank sum test was used to
test the cohort for continuous variables. We also fit the
univariable and multivariable logistic regression models
for the probabilities of patients in “CD” or “UC” groups
about their possible predictors [35]. Furthermore, we
examined haplotype associations between CD and UC.
We performed univariate analysis of our control popu-
lation compared against CD and UC as well as CD
against UC patients. Based on this analysis, we selected
the following most significant IBD clinical predictors:
age at time of diagnosis, gender, smoking status, IBD-
associated surgery, and family history of IBD as descrip-
tive of the IBD subtype. The age at time of diagnosis
w a sd i c h o t o m i z e da s<2 7o r≥ 27 years (as the median
age at time of diagnosis was 27). Using these clinical cri-
teria, we performed multivariable logistic regression ana-
lysis combining both significant genetic and clinical
predictors.
We explored the genotype association, allelic associa-
tion, and Hardy-Weinberg Equilibrium (HWE) test for
11 SNPs using the Pearson Chi-square test. For allelic
association analysis of the 11 SNPs, we used the binary
logistic regression method to estimate their odds ratios
and 95% confidence intervals for patients with CD or
UC as compared to control group. Odds ratios and 95%
confidence intervals were estimated using binary logistic
regression. Since all the studied genes had already been
identified as associated genes for IBD, CD and UC sus-
ceptibility, no multiple testing corrections were required.
Haplotype analysis was conducted for all the SNPs of
NOD2, IL23r and IGR. All calculations were performed
with Statistical Analysis Software (SAS) program [34,36].
A p-value less than or equal to 0.05 was set to be
significant.
Additional material
Additional file 1: The four studied genes (NOD2, IL-23r, OCTN1, and
IGR) along with the corresponding SNPs. A list of the studied Single
Nucleotide Polymorphisms (SNPs) in each gene of interest along with
their reference numbers.
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